November 30, 2021
Due to reagent procurement issues and/or staffing shortages at Versiti, the turn-around-time for this assay may be extended.
An aid in identifying acute myeloid leukemia (AML) patients with an (IDH2) mutation for treatment with IDHIFA® (enasidenib).
Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting
Lavender (EDTA), 4mL
Abbott Realtime IDH2